China has approved a new weight-loss drug that is poised to rival Novo Nordisk and Eli Lilly's popular GLP-1 treatments, ...

The Australian Human Rights Commission is calling for law reforms to protect and support victims of workplace sexual ...

The S&P 500 and Nasdaq hit record highs on Monday, capping a dramatic second quarter that saw stocks rebound from ...

Moderna shares rose on the increased effectiveness of its flu vaccine in late-stage trials, bring the biotech company closer ...

The U.S. dollar is on track for its worst first half since 1973, as tariffs and Fed concerns shake investor confidence in the ...

This year’s Fourth of July cookout will cost $70.92 for 10 people, just below last year’s record high, according to the ...

The WNBA will expand to Detroit, Philadelphia and Cleveland, bringing the total number of franchises over the next five years ...

Starbucks’ China sales is facing headwinds due to rapid expansion by local competitors like Luckin Coffee and shifting ...

Millions of Australians will get a pay rise from July 1 as the minimum wage rises by 3.5%, while employers will also be ...

Private health insurer Bupa has agreed to pay a $35 million penalty after admitting it incorrectly rejected hospital claims ...

The number of US tourists flying to Europe is already up 6% over last year, and Eurostar train bookings by Americans climbed 45% for June and July.

Biopharma company AbbVie will acquire Capstan Therapeutics for up to $2.1 billion in cash, giving it access to promising new cell therapies that could treat autoimmune diseases like lupus.